Inactive Instrument

Amylin Pharmaceuticals LLC Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

02/08/12	Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading	RE
16/07/12	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE

02/08/12	Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading	RE
16/07/12	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE
16/07/12	GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	RE
15/07/12	GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	RE
10/07/12	Forest Laboratories, Inc. : Exclusive: Icahn offered to settle with Forest before battle	RE
10/07/12	Exclusive: Icahn offered to settle with Forest before battle	RE
02/07/12	SANOFI : Icahn return on Amylin tops 35 percent	RE
02/07/12	Bristol Myers Squibb Co. : Bristol's patent woes persist despite Amylin buy	RE
30/06/12	SANOFI : AstraZeneca hungry to refill medicine cabinet	RE
30/06/12	SANOFI : Bristol-Myers to buy Amylin for about $5.3 billion	RE
02/05/12	Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	RE
30/04/12	Ardea Biosciences, Inc. : Warner Chilcott to explore sale of company	RE
25/04/12	Ardea Biosciences, Inc. : Watson to buy Actavis for at least $5.6 billion	RE

09/08/12	Amylin Pharmaceuticals, Inc. : Bristol-Myers Squibb and AstraZeneca Complete Expansion of Diabetes Alliance Through Bristol-Myers Squibb's Acquisition of Amylin	PU
11/07/12	Amylin Pharmaceuticals, Inc. : The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bristol-Myers Squibb Corporation	BU
09/07/12	Amylin Pharmaceuticals, Inc. : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.	PR
07/07/12	Amylin Pharmaceuticals, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.	BU
03/07/12	Amylin Pharmaceuticals, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.	PR

16/07/12	GSK annonce le rachat de Human Genome pour $3,0 milliards
02/07/12	Wall Street termine sans grande tendance après les PMI
02/07/12	USA-Les valeurs à suivre à Wall Street
30/06/12	Le laboratoire Bristol-Myers lance une OPA amicale sur Amylin
31/05/12	Sanofi veut élargir son offre sur le marché du diabète

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REGENERON PHARMACEUTICALS, INC.	+0.61%	+3.43%	+41.41%	+0.28%	82.73B
CSL LIMITED	+2.68%	+29.00%	-19.83%	-34.19%	57.94B
MODERNA, INC.	+14.36%	+146.40%	+485.66%	+40.99%	55.45B
SAMSUNG BIOLOGICS CO.,LTD.	+0.76%	+2.39%	+0.08%	+35.11%	52.57B
UCB	+1.86%	+4.04%	+13.58%	+175.04%	48.94B
BIOGEN INC.	+1.21%	+5.56%	+58.47%	-15.87%	32.23B
INCYTE CORPORATION	+1.36%	+5.04%	+52.54%	+101.96%	25.94B
INNOVENT BIOLOGICS, INC.	+0.60%	+4.98%	+0.65%	+188.89%	22.1B
SWEDISH ORPHAN BIOVITRUM AB	+3.89%	+2.58%	+61.60%	+116.01%	16.55B
Average	+1.43%	+17.75%	+77.13%	+67.58%	43.83B
Weighted average by Cap.	+1.23%	+21.99%	+86.59%	+48.06%

Employees

Sector